GlassScriptPhysician profile
Jessica Bruce
NPI 1346691128
$762.89
in general payments reported to CMS, 2019-2025
15 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.50 · 2023: $168 · 2024: $245 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $221.12 | 2023-2025 | Trelegy Ellipta, Penmenvy, Shingrix |
| Novo Nordisk INC | $144.61 | 2023-2025 | Wegovy |
| Lilly USA, LLC | $72.09 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.63 | 2023-2024 | Xifaxan, Trulance |
| Abbvie INC. | $39.80 | 2022-2023 | |
| Pfizer INC. | $38.53 | 2024-2025 | |
| Dexcom, INC. | $35.80 | 2024-2025 | Dexcom G6 Transmitter |
| Currax Pharmaceuticals LLC | $27.17 | 2024-2025 | Onzetra Xsail, Contrave |
| Edwards Lifesciences Corporation | $24.91 | 2023 | |
| Phathom Pharmaceuticals, INC. | $22.08 | 2024 | Voquezna |
| Amgen INC. | $21.49 | 2024 | Repatha, Otezla |
| Exact Sciences Corporation | $19.07 | 2025 | Cologuard Collection Kit |
| Mirum Pharmaceuticals, INC. | $17.31 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.94 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $13.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.